Follow The Filings

ADGM Adagio Medical Holdings Inc.

Health Care, filed as ADAGIO MED HLDGS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • $13K

Who owns ADGM

Sorted by value, long equity only, as of 2026 Q2.

History
James Silverman, Opaleye Management <0.01% Hold 18,444 $13K History

1 current, options excluded

Insider trades

Open-market buys and sales by ADGM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ADGM insider trades
  • $244K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Deborah Kaster CFO
    Buy
    $18K 15,000 shares at $1.20 New stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
    ↗
  2. Todd Usen CEO
    Buy
    $226K 207,315 shares at $1.09 New stake
    Traded Dec 12, 2025 Filed Dec 15, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.07 Filing Doc
DEF 14A Filing Doc
8-K 3.02 Filing Doc
8-K 2.05,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 3.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K/A FORM 10-K/A Filing Doc
8-K 5.07 Filing Doc
8-K 3.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.08 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
424B3 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Revenue — $0.00
Gross profit * — -$684,000
Net income — -$25.08M

Balance sheet

Metric FY2024 FY2025
Total current assets $25.35M $20.08M
Total non-current assets * $23.1M $23.17M
Total assets $48.45M $43.25M
Total current liabilities $7.76M $8.23M
Total non-current liabilities * $20.77M $22.62M
Total equity -$148.32M $12.4M

Cash flow

Metric FY2024 FY2025
Cash from operations — -$19.01M
Cash from investing — -$374,000
Cash from financing — $16.13M
Net change in cash — -$3.48M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.